Replies to post #145857 on Innovation Pharmaceuticals Inc (IPIX)

[bradfordbros]

Please stay behind so we can enjoy the ride of our lives.

[sox040713]

Glad you are catching up with your investment. If you read the PR from six days ago, you should know what it means.

"Also referred to as a “database freeze,” this step in the regulatory process means all case information has been compiled and put into the database and all known queries have been resolved."

http://cellceutix.com/cellceutix-institutes-database-soft-lock-on-its-phase-2-psoriasis-clinical-trial-top-line-results-anticipated-in-may-additional-company-updates/#sthash.9Un1Y4eK.dpuf";

what's that mean?

[sox040713]

Cash on hand = $6.2M

12-month planned expenses = $22M

Cash needed from Aspire = $22 - $6.2M = $15.8M

$15.8M / $1.77 per share = 8.9M shares

8.9M shares / 120M total OS = ~7.4% dilution

After Aspire, shelf registration = $45M

[edge]

I agree, it's weird. New biotech terminology found at the greatest place on the moon..............Can't make this stuff up.

[RJFL]

Sometimes it's better to remain silent and thought a fool than to speak up and remove all doubt.

"Database soft lock also known as database freeze is a milestone defined in the Statistical Analysis Report and is most commonly defined as the point where all case report form data has been input into the database and all known queries are resolved. When soft lock is declared, the edit rights of all data entry and data management personnel are rescinded so that only the Lead Data Manager has the ability to modify the database."

Source: http://blog.clinfosource.com/guidelines-hard-locking-clinical-research-database/